XML 157 R134.htm IDEA: XBRL DOCUMENT v3.21.1
Note 30 - Share-based Payments (Details Textual)
1 Months Ended 12 Months Ended
Jan. 11, 2021
Feb. 27, 2018
Jul. 31, 2017
GBP (£)
Dec. 31, 2020
USD ($)
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Sep. 30, 2020
Statement Line Items [Line Items]              
Expense from cash-settled share-based payment transactions       $ 634,000 $ 107,000 $ 43,000  
Expense from cash-settled share-based payment transactions in which goods or services received did not qualify for recognition as assets       $ 1,413,000 $ 689,000 $ 315,000  
Option life, share options granted   3          
Share-based compensation arrangement, percentage of outstanding stock maximum       10.00%      
Weighted average remaining contractual life of outstanding share options (Year)       1 year 295 days 2 years 51 days 3 years 51 days  
Expense from equity-settled share-based payment transactions in which goods or services received did not qualify for recognition as assets       $ 14,000  
Mr. J Staiger [member]              
Statement Line Items [Line Items]              
Expense from equity-settled share-based payment transactions in which goods or services received did not qualify for recognition as assets       $ 0 0 $ 14,000  
Restricted stock units (RSUs) [member]              
Statement Line Items [Line Items]              
Vesting period of other equity instruments       3      
Weighted average fair value at measurement date, other equity instruments granted       $ 15.88 8.46    
Performance share units (PSUs) [member]              
Statement Line Items [Line Items]              
Vesting period of other equity instruments       3      
Performance probability           85.00%  
Liabilities from share-based payment transactions       $ 2,240,000 524,000 $ 2,043,000  
Expense from cash-settled share-based payment transactions       634,000 107,000 43,000  
Value of other equity instruments exercised or vested in share-based payment arrangement, share capital       216,000      
Weighted average fair value at measurement date, other equity instruments granted       $ 15.51 $ 8.19    
Performance share units (PSUs) [member] | Potential ordinary share transactions [member]              
Statement Line Items [Line Items]              
Number of other equity instruments granted in share-based payment arrangement 78,883            
Performance share units (PSUs) [member] | Bottom of range [member]              
Statement Line Items [Line Items]              
Performance probability       93.00% 93.00%    
Performance share units (PSUs) [member] | Top of range [member]              
Statement Line Items [Line Items]              
Performance probability       100.00% 100.00%    
Cash-settled awards [member]              
Statement Line Items [Line Items]              
Vesting period of other equity instruments     3        
Liabilities from share-based payment transactions       $ 30,000 $ 16,000 47,000  
Number of other equity instruments granted in share-based payment arrangement     52,282        
Weighted average fair value at measurement date, other equity instruments granted | £     £ 12.05        
Expense from cash-settled share-based payment transactions in which goods or services received did not qualify for recognition as assets       $ 114,000 $ 73,000 $ 97,000  
Percentage of discretionary cash bonus             10.00%
Omnibus Equity Incetive Compensation Plan [member]              
Statement Line Items [Line Items]              
Option life, share options granted       10